DarioHealth, a digital therapeutics company focused on chronic care, has entered into a USD 30 million multi-year strategic collaboration with pharma giant Sanofi to expand its market reach within the US. Following the announcement, Dario’s stock rose 12% premarket.
Under the terms of the deal, Sanofi’s US division will help promote Dario’s multi-condition platform among employers and insurance providers to improve adoption and sales. Additionally, the companies plan to develop and commercialize new digital therapeutic products for the latter’s platform.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.